Stock listing
A3EJMQ Stock Price, News, Filings & Events — Santhera Pharmaceuticals Holding Ag
Selected listing: A3EJMQ · LSX · EUR · DE
This page tracks Santhera Pharmaceuticals Holding Ag's A3EJMQ:LSX listing on LSX in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following A3EJMQ:LSX. A3EJMQ:LSX is the stock-level entry point for investors researching Santhera Pharmaceuticals Holding Ag, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary.
- Ticker
- A3EJMQ:LSX
- Asset type
- Stock
- Market cap
- $287.1M
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- LSX
- Currency
- EUR
Santhera Pharmaceuticals Holding Ag A3EJMQ:LSX stock context
This page tracks Santhera Pharmaceuticals Holding Ag's A3EJMQ:LSX listing on LSX in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following A3EJMQ:LSX. A3EJMQ:LSX is the stock-level entry point for investors researching Santhera Pharmaceuticals Holding Ag, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary.
Latest news from Santhera Pharmaceuticals Holding Ag
Santhera Expands Biomedica Agreement to Extend AGAMREE® (Vamorolone) Distribution Across Central Asia and the Caucasus
July 13, 2026
Santhera Announces Orphan Drug and Priority Review Designations for AGAMREE® (Vamorolone) in South Korea
June 2, 2026
Santhera Proposes Dr. Srishti Gupta as New Member of the Board of Directors
April 30, 2026
Santhera Announces Positive AIFA Board Decision on Reimbursement of AGAMREE® (vamorolone) in Italy
April 28, 2026
Santhera Pharmaceuticals Full Year Results for the Year Ended 31 December 2025
April 28, 2026
Santhera Pharmaceuticals Holding Ag earnings calls
Santhera Pharmaceuticals Holding AG (0QN1) Q4 2025 Earnings Call
April 28, 2026 · Replay with transcript and chapters
Santhera Pharmaceuticals Holding AG (0QN1) Q2 2025 Earnings Call
September 23, 2025 · Replay with transcript and chapters
Santhera Pharms Hldgs Ltd (SPHDF) Q4 2024 Earnings Call
September 12, 2024 · Replay with transcript and chapters
Research Santhera Pharmaceuticals Holding Ag
Santhera Pharmaceuticals Holding Ag investor report
Review AI stock analysis and investor report context for A3EJMQ:LSX.
Santhera Pharmaceuticals Holding Ag company profile
View the public company page for Santhera Pharmaceuticals Holding Ag on 6ix.
Santhera Pharmaceuticals Holding Ag news
Read company news and market updates connected to Santhera Pharmaceuticals Holding Ag.
Santhera Pharmaceuticals Holding Ag investor events
Find investor webinars, events, and replay context for Santhera Pharmaceuticals Holding Ag.
Alternate listings
SANN:SIX
CH · CHF
Alternate listing for Santhera Pharmaceuticals Holding Ag; the primary context on this page is A3EJMQ:LSX.
SPHDF:OTC
US · USD
Alternate listing for Santhera Pharmaceuticals Holding Ag; the primary context on this page is A3EJMQ:LSX.
0QN1:LSE
GB · CHF
Alternate listing for Santhera Pharmaceuticals Holding Ag; the primary context on this page is A3EJMQ:LSX.
S3F0:GETTEX
DE · EUR
Alternate listing for Santhera Pharmaceuticals Holding Ag; the primary context on this page is A3EJMQ:LSX.
A3EJMQ:LS
DE · EUR
Alternate listing for Santhera Pharmaceuticals Holding Ag; the primary context on this page is A3EJMQ:LSX.
SANNZ:AQUISUK
GB · CHF
Alternate listing for Santhera Pharmaceuticals Holding Ag; the primary context on this page is A3EJMQ:LSX.
S3F0:BX
CH · CHF
Alternate listing for Santhera Pharmaceuticals Holding Ag; the primary context on this page is A3EJMQ:LSX.
S3F0:TRADEGATE
DE · EUR
Alternate listing for Santhera Pharmaceuticals Holding Ag; the primary context on this page is A3EJMQ:LSX.
S3F0:DUS
DE · EUR
Alternate listing for Santhera Pharmaceuticals Holding Ag; the primary context on this page is A3EJMQ:LSX.
S3F0:FWB
DE · EUR
Alternate listing for Santhera Pharmaceuticals Holding Ag; the primary context on this page is A3EJMQ:LSX.
S3F0:HAM
DE · EUR
Alternate listing for Santhera Pharmaceuticals Holding Ag; the primary context on this page is A3EJMQ:LSX.
S3F0:MUN
DE · EUR
Alternate listing for Santhera Pharmaceuticals Holding Ag; the primary context on this page is A3EJMQ:LSX.